KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $2.4 billion.

  • Novartis Ag's Profit After Tax fell 1475.18% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $14.0 billion, marking a year-over-year increase of 1698.63%. This contributed to the annual value of $14.0 billion for FY2025, which is 1698.63% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Profit After Tax is $2.4 billion, which was down 1475.18% from $3.9 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Profit After Tax ranged from a high of $16.3 billion in Q4 2021 and a low of $1.3 billion during Q3 2022
  • Over the past 5 years, Novartis Ag's median Profit After Tax value was $2.7 billion (recorded in 2021), while the average stood at $3.4 billion.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 67684.61% in 2021, then crashed by 9100.94% in 2022.
  • Novartis Ag's Profit After Tax (Quarter) stood at $16.3 billion in 2021, then tumbled by 91.01% to $1.5 billion in 2022, then soared by 201.57% to $4.4 billion in 2023, then plummeted by 36.21% to $2.8 billion in 2024, then fell by 14.75% to $2.4 billion in 2025.
  • Its Profit After Tax was $2.4 billion in Q4 2025, compared to $3.9 billion in Q3 2025 and $4.0 billion in Q2 2025.